No black box warning on record for Rylaze
As of the latest FDA labeling reviewed, Rylaze (ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Rylaze medicine page for the complete safety profile.